GlaxoSmithKline completes purchase of Block Drug for $1.24 Billion
cquisition expands GlaxoSmithKline's presence in oral healthcare and over-the-counter medicines
24-Jan-2001 -
GlaxoSmithKline plc (GSK) today
announced the successful completion of its acquisition of
Block Drug Company, Inc., the manufacturer of
Sensodyne toothpaste and other oral healthcare and
consumer products, for $1.24 billion.
"This acquisition will significantly enhance our Consumer
...
GlaxoSmithKline
GSK
Japan
+1